Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-17

Clinical Trial Update: Fourteen-Day Vonoprazan-Based Dual Therapy With Amoxicillin as First-Line Helicobacter Pylori Treatment in Comparison With Extended Sequential Therapy [Phase 4]

View source ↗

Summary

A Phase 4 trial compared a fourteen-day vonoprazan-based dual therapy with amoxicillin against extended sequential therapy as first-line treatment for Helicobac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMOXICILLIN (AMOXICILLIN)
  • Vonoprazan (vonoprazan)

Snippet

Sponsor: Fu Jen Catholic University Hospital | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: COMPLETED